Last reviewed · How we verify

NCT04324788

Investigation of the Effect of Stair Activity on Lumbal Paravertebral Mechanical Properties in Amputes.

Completed Last updated 4 October 2021
What this trial tests

trial testing Group 1 in Stair up and Down, Amputation in 28 participants. Completed in 20 December 2020.

Timeline
1 February 2020
Primary endpoint
15 April 2020
20 December 2020

Quick facts

Lead sponsorMarmara University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment28
Start date1 February 2020
Primary completion15 April 2020
Estimated completion20 December 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 55, male only, with Stair up and Down, Amputation or Amputation,Stair up and Down. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the onset of prosthesis use following lower extremity amputations,body shows biomechanical changes according to the amputation level and consequently develops adaptation mechanisms both on the healthy and ampute side. Adaptations in the lumbo-pelvic and lower lumbar regions cause asymmetries in the muscle tissue by causing changes in the morphological structure of the muscle, especially in the muscles of the waist, hip and knee and recruitment. The aim of this study is to investigate the effect of stairing up and down activity on the mechanical properties of lumbal paravertebral muscles in TFA and TTA and its relation with lower lumbar region pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Group 1

Trials testing the same drug.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04324788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing